7776 — CellSeed Income Statement
0.000.00%
Last trade - 00:00- ¥20bn
- ¥18bn
- ¥193m
Annual income statement for CellSeed, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 199 | 162 | 126 | 190 | 193 |
| Cost of Revenue | |||||
| Gross Profit | 138 | 84 | 61 | 107 | 110 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 954 | 1,050 | 874 | 1,023 | 1,050 |
| Operating Profit | -755 | -888 | -748 | -833 | -856 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -780 | -911 | -759 | -846 | -858 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -784 | -915 | -760 | -847 | -860 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -784 | -915 | -760 | -847 | -860 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -784 | -915 | -760 | -847 | -860 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -53.7 | -52.3 | -36.2 | -26.4 | -25.5 |
| Dividends per Share |